Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Been thinking

Been thinking

posted on Feb 02, 2010 12:28PM

Perhaps trying to change the bylaws is not the best way to bring about changes that the majority of shareholders may want.

If the majority of shareholders want to see a change in the directors, wouldn't it be in our best interest to nominate more directors than there are seats? Right now there are five seats and we voted for five directors, all nominated by the nominating committee.

With plurality voting, it wouldn't matter if one of those people got only one vote...they would be elected. Now if we could get recommendations from someone like Baroni, perhaps the shareholders could then request that several more names be included for the next election. If we have five seats next year and seven running, then it would seem that the majority of votes would prevail. Am I thinking correctly or is there a flaw somewhere?

Perhaps the flaw is in thinking that the current BoD would actually allow us to nominate more than five. Comments?

2
Feb 02, 2010 12:53PM
1
Feb 02, 2010 01:08PM
2
Feb 02, 2010 02:27PM
3
Feb 02, 2010 03:31PM

Feb 02, 2010 10:07PM
Share
New Message
Please login to post a reply